The scientist’s investigation covers issues in Cervical cancer, Internal medicine, HPV infection, Immunology and Papillomaviridae. Her Cervical cancer course of study focuses on Epidemiology and Sex organ and Etiology. Her Internal medicine research integrates issues from Oncology and Vaccine efficacy.
Luisa L. Villa interconnects Incidence, Young adult, Gynecology, Disease and Prospective cohort study in the investigation of issues within HPV infection. The concepts of her Immunology study are interwoven with issues in Papillomavirus Vaccines and Human papillomavirus. Luisa L. Villa has researched Papillomaviridae in several fields, including Cervix, Genome, Phylogenetic tree and Phylogenetics.
Luisa L. Villa mainly focuses on HPV infection, Cervical cancer, Internal medicine, Gynecology and Immunology. Her HPV infection study combines topics in areas such as Young adult, Papillomaviridae, Sex organ and Incidence. Her studies in Cervical cancer integrate themes in fields like Odds ratio, Epidemiology and Vaccination.
Her studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine. Her Gynecology research is multidisciplinary, relying on both Cervix, Prospective cohort study, Risk factor and Obstetrics. Her research investigates the connection with Human papillomavirus and areas like Virology which intersect with concerns in Polymerase chain reaction and Genome.
Her main research concerns HPV infection, Internal medicine, Sex organ, Cervical cancer and Cancer research. Her work carried out in the field of HPV infection brings together such families of science as Incidence, Young adult, Immunology, Gynecology and Genital warts. Her Gynecology research incorporates themes from Poisson regression and Anal cancer.
Luisa L. Villa combines subjects such as Gastroenterology and Oncology with her study of Internal medicine. Her Sex organ research includes elements of Hpv types, Genotyping, Epidemiology and Cohort study. Her Cervical cancer and Cervical intraepithelial neoplasia and Papillomaviridae investigations all form part of her Cervical cancer research activities.
Her primary areas of study are HPV infection, Sex organ, Gynecology, Cervical cancer and Internal medicine. The HPV infection study combines topics in areas such as Young adult, Prospective cohort study, Incidence and Genital warts. The study incorporates disciplines such as Genotyping and Obstetrics in addition to Sex organ.
Her Gynecology research is multidisciplinary, incorporating perspectives in Test and Follow up studies. Her research on Cervical cancer focuses in particular on Papillomaviridae. Her research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Human papillomavirus, Clinical efficacy, Clinical trial, HPV vaccines and Cancer prevention.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen.
The New England Journal of Medicine (2007)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade.
Lancet Oncology (2005)
Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High-Risk Area for Cervical Cancer
Eduardo L. Franco;Luisa L. Villa;Joao P. Sobrinho;José M. Prado.
The Journal of Infectious Diseases (1999)
HPV type-distribution in women with and without cervical neoplastic diseases
Gary Clifford;Silvia Franceschi;Mireia Diaz;Nubia Munoz.
Vaccine. Supplement (2006)
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
Nicolas F. Schlecht;Sophie Kulaga;Juliette Robitaille;Silvaneide Ferreira.
JAMA (2001)
Updating the natural history of HPV and anogenital cancer
Anna-Barbara Moscicki;Mark Schiffman;Susanne Kjaer;Luisa L. Villa.
Vaccine. Supplement (2006)
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.
Gary Clifford;Silvia Franceschi;Mireia Diaz;Nubia Muñoz.
Vaccine (2006)
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L. L. Villa;R. L. R. Costa;C. A. Petta;R. P. Andrade.
British Journal of Cancer (2006)
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Luisa L. Villa;Kevin A. Ault;Anna R. Giuliano;Ronaldo L.R. Costa.
Vaccine (2006)
Chapter 5: Updating the natural history of HPV and anogenital cancer.
Anna-Barbara Moscicki;Mark Schiffman;Susanne Kjaer;Luisa L. Villa.
Vaccine (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of South Florida
McGill University
Albert Einstein College of Medicine
International Agency For Research On Cancer
Karolinska University Hospital
University of Washington
Open University of Catalonia
University of Helsinki
University of Virginia
University of Copenhagen
École Polytechnique Fédérale de Lausanne
Maastricht University
University of California, Los Angeles
Nokia (United States)
Utrecht University
Pontificia Universidad Católica de Chile
ETH Zurich
Zhejiang University
Indiana University
Birkbeck, University of London
Genentech
Poznan University of Medical Sciences
University of London
Uppsala University
University of London
University of Edinburgh